GlassScriptPhysician profile
Ali Fadhil
NPI 1144684374
$12,465.09
in general payments reported to CMS, 2019-2025
17 companies · $9,319 in 2025
The $9,319 reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.79 · 2020: $132 · 2021: $113 · 2022: $164 · 2023: $210 · 2024: $2,470 · 2025: $9,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,586 · Food and Beverage: $4,133 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,585.86 |
| Food and Beverage | $4,133.38 |
| Education | $279.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,021.08 | 2023-2025 | Penumbra System, Smart Coil, Red 72 |
| Stryker Corporation | $2,934.87 | 2023-2025 | Evolve, Neuroform Ez 3, Target |
| Microvention, INC. | $2,155.77 | 2025 | Web Aneurysm Embolization System |
| Medical Device Business Services, INC. | $1,020.59 | 2024-2025 | Trufill, Embotrap, Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device |
| Balt USA, LLC | $562.89 | 2024-2025 | Optima Coil System, Raptor Aspiration Catheter |
| Depuy Synthes Sales INC. | $555.34 | 2023-2025 | Trufill, Embotrap, Emboguard |
| Abbvie INC. | $320.47 | 2023-2024 | |
| Medtronic, INC. | $232.43 | 2024-2025 | Onyx 18 |
| Novo Nordisk INC | $124.45 | 2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $123.77 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $100.85 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $89.54 | 2020-2022 | |
| Cequr Corporation | $71.33 | 2024 | Cequr Simplicity |
| Portola Pharmaceuticals, LLC | $44.38 | 2020 | |
| Genentech USA, INC. | $37.44 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $36.45 | 2019-2022 | |
| Csl Behring | $33.44 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Fadhil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.